Identification and Validation of the lncRNA BACE1-AS as Immune-Related Influencing Factor in Tumorigenesis following Pan-Carcinoma Analysis

Table 2

Correlation between BACE1-AS expression and tumor mutation load.

Cancer type	TMB		MSI
		value		value
ACC	0.29	<0.01	-0.22	<0.05
BLCA	-0.06	0.26	0.10	<0.05
BRCA	-0.15	<0.001	0.00	0.92
CESC	0.00	0.99	0.06	0.33
CHOL	-0.09	0.61	0.19	0.25
COAD	-0.07	0.18	-0.12	<0.05
DLBC	-0.30	0.07	-0.30	<0.05
ESCA	0.06	0.44	0.08	0.35
GBM	0.03	0.71	0.09	0.27
HNSC	-0.10	<0.05	0.07	0.13
KICH	-0.02	0.90	0.07	0.56
KIRC	-0.05	0.37	-0.15	<0.01
KIRP	0.02	0.77	-0.03	0.58
LAML	0.43	<0.001	0.19	0.11
LIHC	0.07	0.19	0.06	0.24
LUAD	0.08	0.06	0.30	<0.001
LUSC	0.05	0.28	0.26	<0.001
MESO	0.09	0.42	-0.01	0.96
OV	-0.03	0.57	0.10	0.11
PAAD	-0.13	0.10	-0.10	0.21
PCPG	-0.01	0.85	0.08	0.29
PRAD	0.04	0.42	0.12	<0.01
READ	0.12	0.16	0.14	0.09
SARC	-0.15	<0.05	0.00	0.95
SKCM	-0.05	0.33	0.01	0.83
STAD	-0.05	0.36	0.11	<0.05
TGCT	0.01	0.92	-0.30	<0.001
THCA	-0.02	0.72	0.10	<0.05
THYM	0.29	<0.01	-0.05	0.60
UCEC	-0.02	0.61	0.06	0.20
UCS	-0.19	0.17	-0.24	0.08
UVM	-0.02	0.87	-0.17	0.14